Ann: Nyrada Commences Walter Reed Traumatic Brain Injury Study, page-180

  1. 1,477 Posts.
    lightbulb Created with Sketch. 193
    lol Zecs I love how you dum down anything the company does your a smart downramper. The company drug is revolutionary I love how you dum down that as well ahhahah and of course they need to pay for it. Walter Reed is funded by the company proving it up. I don’t know why I reply to you

    Mate Walter Reed provides the company with evidence for the TBI indication and allows them to apply with the US defence force for non dilutive funding which the CEO has stated in every interview which funds their phase 2. Now if you want to downramp every little thing and dum down the company because you lost money keep going lol the company is not reliant on Walter Reed results. The cardiovascular protection market is a 5 billion dollar unmet market.

    They are about to get ethical approval and start their first human dosing. Once they clear safety the company is on its way. GLP studies already heavily de risked this and hence why they raised at 12 cents. Comes down goes straight back up either way just plain stupid and bought more today. You can keep downramping a company fully funded through to phase 2 and non dilutive funding. Ton of news flow coming in going to run either way


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
37.0¢
Change
0.000(0.00%)
Mkt cap ! $78.03M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
3 1642 37.0¢
 

Sellers (Offers)

Price($) Vol. No.
37.0¢ 682527 2
View Market Depth
Last trade - 14.40pm 31/07/2025 (20 minute delay) ?
NYR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.